Matsuo H - Search Results

1

The efficacy of interferon-alpha treatment in human T-lymphotropic virus type-I-associated myelopathy.

Nakamura T, Shibayama K, Nagasato K, Matsuo H, Tsujihata M, Nagataki S. Nakamura T, et al. Among authors: matsuo h. Jpn J Med. 1990 Jul-Aug;29(4):362-7. doi: 10.2169/internalmedicine1962.29.362. Jpn J Med. 1990. PMID: 2273619 Free article.

2

Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy.

Matsuo H, Nakamura T, Tsujihata M, Kinoshita I, Satoh A, Tomita I, Shirabe S, Shibayama K, Nagataki S. Matsuo H, et al. Lancet. 1988 Nov 12;2(8620):1109-13. doi: 10.1016/s0140-6736(88)90525-9. Lancet. 1988. PMID: 2903326

3

Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.

Matsuo H, Nakamura T, Shibayama K, Motomura M, Nagasato K, Takeo G, Tsujihata M, Nagataki S. Matsuo H, et al. Curr Stud Hematol Blood Transfus. 1990;(57):198-207. doi: 10.1159/000418560. Curr Stud Hematol Blood Transfus. 1990. PMID: 2272201 No abstract available.

4

Human T-lymphotropic virus type I(HTLV-I) associated myelopathy in Nagasaki: clinical features and treatment of 21 cases.

Matsuo H, Nakamura T, Tsujihata M, Motomura M, Nagasato K, Nagataki S. Matsuo H, et al. Jpn J Med. 1989 May-Jun;28(3):328-34. doi: 10.2169/internalmedicine1962.28.328. Jpn J Med. 1989. PMID: 2661889 Free article. Review.

5

'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.

Ohtsuru I, Matsuo H, Fukudome T, Suenaga A, Tsujihata M, Nagataki S. Ohtsuru I, et al. Among authors: matsuo h. Clin Exp Immunol. 1995 Dec;102(3):462-7. doi: 10.1111/j.1365-2249.1995.tb03838.x. Clin Exp Immunol. 1995. PMID: 8536358 Free PMC article.

6

Myasthenogenicity of a human acetylcholine receptor alpha-subunit peptide: morphology and immunology.

Matsuo H, Tsujihata M, Satoh A, Takeo G, Yoshimura T, Nagataki S. Matsuo H, et al. Muscle Nerve. 1992 Mar;15(3):282-7. doi: 10.1002/mus.880150305. Muscle Nerve. 1992. PMID: 1372965

7

Magnetic resonance imaging in diagnosis and follow-up of minimal thyroid ophthalmopathy.

Matsuo H, Motomura M, Takeo G, Yoshimura T, Tsujihata M, Nagataki S. Matsuo H, et al. Jpn J Med. 1991 May-Jun;30(3):229-32. doi: 10.2169/internalmedicine1962.30.229. Jpn J Med. 1991. PMID: 1920963 Free article.

8

Characterization of HTLV-I in a T-cell line established from a patient with myelopathy.

Nakamura T, Tsujihata M, Shirabe S, Matsuo H, Ueki Y, Nagataki S. Nakamura T, et al. Among authors: matsuo h. Arch Neurol. 1989 Jan;46(1):35-7. doi: 10.1001/archneur.1989.00520370037015. Arch Neurol. 1989. PMID: 2642698

9

Central motor conduction time in patients with HTLV-1 associated myelopathy.

Tomita I, Shibayama K, Matsuo H, Kinoshita I, Tsujihata M, Nagataki S. Tomita I, et al. Among authors: matsuo h. Acta Neurol Scand. 1989 May;79(5):419-27. doi: 10.1111/j.1600-0404.1989.tb03810.x. Acta Neurol Scand. 1989. PMID: 2741672

10

Role of the macrophage in the pathogenesis of experimental autoimmune myasthenia gravis.

Kinoshita I, Nakamura T, Satoh A, Matsuo H, Seto M, Tomita I, Tsujihata M, Nagataki S. Kinoshita I, et al. Among authors: matsuo h. J Neurol Sci. 1988 Oct;87(1):49-59. doi: 10.1016/0022-510x(88)90053-6. J Neurol Sci. 1988. PMID: 2848094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,306 results

Search Page

Filters